ARCHIVES

Also NCI appoints members of Clinical Trials Working Group to review trials system.

This article is from The Cancer Letter archive.

Vol. 30 No. 02 | January 9, 2004

Download PDF Visit The Full Archive

Related Articles

Letter: A Modest Proposal To Abolish FDA

January 26, 1996

ODAC Recommends Approval Of Nplate For Thrombocytopenia.

March 21, 2008

Holden Center At U. Of Iowa Designated Comprehensive.

January 26, 2001

Bishop: Cells, Genes Reveal Unified Strategy For Cancer Conquest

March 3, 1995

NCI Hits Grant Targets, But Labs Feel The Pain Of Budget Cuts, Director Says.

November 23, 2007

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

August 28, 2009